top of page
GUIDELINE FOR DEPRESCRIBING OPIOID ANALGESICS
Guideline Development Group
Our multidisciplinary guideline development group consists of 17 members.
The group is comprised of:
-
Healthcare professionals with experience in caring for persons taking opioids (general practitioners, pain specialists, addiction specialists, registered nurses, pharmacists, physiotherapists) .
-
Researchers with expertise in pain management and/or deprescribing in Australia and internationally.
-
Methodologists with expertise in deprescribing guideline development, conducting systematic reviews, and the GRADE approach.
-
Implementation experts.
-
Organisational representative.
-
Consumer representative.
Table 1: Guideline development group members, affiliations and roles
Name | Organisational affiliation(s) | Discipline/role/expertise |
|---|---|---|
Ms Aili V Langford | Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia | Pharmacist, PhD Candidate |
Associate Professor Danijela Gnjidic | Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia | Deprescribing Expert,
Pharmacologist |
Dr Carl R Schneider | Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia | Registered Nurse,
Pharmacist |
Professor Chung-Wei Christine Lin | Institute of Musculoskeletal Health, School of Public Health, The University of Sydney, Sydney, Australia | Physiotherapist,
Methodologist |
Professor Lisa Bero | University of Colorado Anschutz Medical Center, Schools of Medicine and Public Health | Methodologist,
Systematic Review Expert |
Professor Fiona M Blyth | School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia | Public Health Physician,
Pain Epidemiologist |
Dr Simon Holliday | School of Medicine and Public Health, University of Newcastle, NSW, Australia. NSW
HealthHub Taree, NSW, Australia | General Practitioner,
Addiction Medicine |
Professor Jason N Doctor | Sol Price School of Public Policy, University of Southern California, Los Angeles, California, USA | Behavioural Scientist,
Implementation Expert |
Professor Yun-Hee Jeon | Sydney Nursing School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia | Registered Nurse,
Nurse Gerontologist,
Methodologist |
Dr Joanna C Moullin | School of Population Health, Faculty of Health Sciences, Curtin University, Perth, Australia | Implementation Scientist,
Pharmacist |
Associate Professor Bridin Murnion | Discipline of Addiction Medicine, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia | Clinical Pharmacologist,
Addiction Medicine,
Pain Medicine |
Associate Professor Suzanne Nielsen | Monash Addiction Research Centre, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia | Content Expert, Pharmacist |
Ms Rawa Osman | NPS MedicineWise, Sydney, Australia | Organisational Representative,
Pharmacist |
Dr Jonathan Penm | Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia | Pharmacist,
Content Expert |
Dr Emily Reeve | Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, Australia | Pharmacist,
Deprescribing Expert,
Deprescribing Guidelines Expert |
Dr Sharon Reid | Royal Australian College of General Practitioners.
Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
Drug Health Services, Sydney Local Health District, Sydney, Australia. | General Practitioner, Addiction Medicine |
Dr Janney Wale |
Independent consumer representative | Community Engagement |
Page 1 of 1
bottom of page